YUVEZZI™ from Tenpoint Therapeutics, Ltd. Is Now Available Nationwide Across the United States

LONDON & SEATTLE--(BUSINESS WIRE)--Tenpoint Therapeutics, Ltd., a global, commercial-stage ophthalmic pharmaceutical company focused on developing groundbreaking treatments to improve vision in the aging eye, today announced that YUVEZZI™ (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is now available in the United States for the treatment of presbyopia in adults. Presbyopia, the gradual loss of close-up vision that typically begins around age 45, affects about 128 million